Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000905718-20-000905
Filing Date
2020-08-27
Accepted
2020-08-27 15:36:52
Documents
1
Effectiveness Date
2020-08-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12149
  Complete submission text file 0000905718-20-000905.txt   13465
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-374299 | Film No.: 201142435
SIC: 2834 Pharmaceutical Preparations